drugset / Trial / NCT02001298

Remifentanil and Nitroprusside for Controlled Hypotension

NCT02001298

RandomizedParallel-groupOpen-label

Summary

The purpose of this study is the comparison of the cardiovascular effects of remifentanil and nitroprusside for controlled hypotension

Timeline

Start
2012-06
Primary completion
2013-07
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Remifentanil Small molecule
Subject nitroprusside Other / unclassified

Indications